Stay updated on APR-246 & Azacitidine in TP53 MDS Clinical Trial
Sign up to get notified when there's something new on the APR-246 & Azacitidine in TP53 MDS Clinical Trial page.

Latest updates to the APR-246 & Azacitidine in TP53 MDS Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe history page shows a new revision entry 'Revision: v3.3.3' and removes 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe history now shows a new revision entry v3.3.2 and removes v3.2.0, reflecting an update to the record-keeping. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoval of the government funding/operating status banner from the page. No other changes to the study history content are shown.SummaryDifference0.6%

- Check71 days agoChange DetectedVersion 2025-03-06 shows updates to the Study Status and Contacts/Locations sections in the record history, indicating changes to the trial's current status. The updated entries reflect the latest status and contact information for the study.SummaryDifference0.1%

- Check92 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference11%

- Check100 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.3%

Stay in the know with updates to APR-246 & Azacitidine in TP53 MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APR-246 & Azacitidine in TP53 MDS Clinical Trial page.